EBOS Group Limited (EBOSF)
- Previous Close
20.02 - Open
20.50 - Bid --
- Ask --
- Day's Range
20.50 - 20.50 - 52 Week Range
20.02 - 28.25 - Volume
3,465 - Avg. Volume
0 - Market Cap (intraday)
4.273B - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
22.28 - EPS (TTM)
0.92 - Earnings Date Aug 19, 2025
- Forward Dividend & Yield 0.71 (3.46%)
- Ex-Dividend Date Feb 27, 2025
- 1y Target Est
--
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
www.ebosgroup.comRecent News: EBOSF
View MorePerformance Overview: EBOSF
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS (^NZ50) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EBOSF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EBOSF
View MoreValuation Measures
Market Cap
4.47B
Enterprise Value
5.44B
Trailing P/E
22.38
Forward P/E
24.10
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.46
Price/Book (mrq)
2.45
Enterprise Value/Revenue
0.60
Enterprise Value/EBITDA
13.40
Financial Highlights
Profitability and Income Statement
Profit Margin
1.95%
Return on Assets (ttm)
4.15%
Return on Equity (ttm)
10.37%
Revenue (ttm)
12.6B
Net Income Avi to Common (ttm)
245.86M
Diluted EPS (ttm)
0.92
Balance Sheet and Cash Flow
Total Cash (mrq)
237.93M
Total Debt/Equity (mrq)
70.12%
Levered Free Cash Flow (ttm)
338.65M